| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2987854 | Journal of Vascular Surgery | 2015 | 10 Pages |
Abstract
The Valiant Mona LSA system demonstrates technical and treatment success, relative safety, and early durability in its initial use in DTA patients. Midterm results are expected as patients are monitored at regular intervals to 5Â years.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Eric E. MD, Frank R. MD, Matthew M. MD, Valiant Mona LSA Trial Investigators Valiant Mona LSA Trial Investigators,